Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

NCT00578097 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

81

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated early due to poor recruitment.

Conditions

Overactive Bladder

Interventions

BIOLOGICAL: Botulinum toxin type A
DRUG: Placebo

Sponsor

Ipsen